Jim Simons Avenue Therapeutics Inc

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$92.4

Avg closing price
Price range
Jim Simons Portfolio Stock Details (ATXI)

15 Jim Simons Avenue Therapeutics Trades

The first Avenue Therapeutics trade was made in Q1 2019. Since then Jim Simons bought shares eight more times and sold shares on six occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Avenue Therapeutics anymore.

Avg closing price
Price range
Sold -213 shares Q2 2023
Avg closing price $82.35
Price range $68.17 - $96.74
New holding (+213 shares) Q1 2023
Avg closing price $92.39
Price range $78.00 - $149.25
Sold -110 shares Q3 2022
Avg closing price $306.60
Price range $4.50 - $756.00
New holding (+110 shares) Q2 2022
Avg closing price $385.18
Price range $247.50 - $628.99
Sold -104 shares Q4 2021
Avg closing price $1,445.92
Price range $991.13 - $2,002.28
Increased shares by 50.7% (+35 shares) Q3 2021
Avg closing price $2,066.31
Price range $1,665.00 - $2,981.25
New holding (+69 shares) Q2 2021
Avg closing price $4,935.00
Price range $2,711.25 - $7,998.75
Sold -67 shares Q4 2020
Avg closing price $5,165.51
Price range $67.95 - $12,420.00
Sold 38.5% shares (-42 shares) Q3 2020
Avg closing price $12,153.34
Price range $10,541.25 - $13,567.50
Increased shares by 86.4% (+51 shares) Q2 2020
Avg closing price $11,282.95
Price range $9,326.25 - $12,903.75
Increased shares by 436.4% (+48 shares) Q1 2020
Avg closing price $10,020.61
Price range $7,245.00 - $12,735.00
New holding (+11 shares) Q4 2019
Avg closing price $6,988.46
Price range $5,923.13 - $10,800.00
Sold -14 shares Q3 2019
Avg closing price $6,809.84
Price range $6,277.50 - $7,087.50
Increased shares by 55.6% (+5 shares) Q2 2019
Avg closing price $5,789.59
Price range $4,871.25 - $7,357.50
New holding (+9 shares) Q1 2019
Avg closing price $6,376.05
Price range $5,343.75 - $7,413.75
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.